AAAAAA
Results:
1-8
|
Results: 8
Authors:
Barbey, JT
Citation: Jt. Barbey, Drug-induced torsade de pointes: the perspectives of industry, EUR H J SUP, 3(K), 2001, pp. K112-K113
Authors:
Abernethy, DR
Wesche, DL
Barbey, JT
Ohrt, C
Mohanty, S
Pezzullo, JC
Schuster, BG
Citation: Dr. Abernethy et al., Stereoselective halofantrine disposition and effect: concentration-relatedQTc prolongation, BR J CL PH, 51(3), 2001, pp. 231-237
Authors:
Abernethy, DR
Barbey, JT
Franc, J
Brown, KS
Feirrera, I
Ford, N
Salazar, DE
Citation: Dr. Abernethy et al., Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation, CLIN PHARM, 69(3), 2001, pp. 96-103
Authors:
Saul, JP
Ross, B
Schaffer, MS
Beerman, L
Melikian, AP
Shi, J
Williams, J
Barbey, JT
Jin, J
Hinderling, PH
Citation: Jp. Saul et al., Pharmacokinetics and pharmacodynamics of sotalol in a pediatric populationwith supraventricular and ventricular tachyarrhythmia, CLIN PHARM, 69(3), 2001, pp. 145-157
Authors:
Barbey, JT
Citation: Jt. Barbey, Cardiac toxicity of arsenic trioxide, BLOOD, 98(5), 2001, pp. 1632-1632
Authors:
Barbey, JT
Soignet, S
Citation: Jt. Barbey et S. Soignet, Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemia, ANN INT MED, 135(9), 2001, pp. 842-842
Authors:
Barbey, JT
Anderson, M
Ciprandi, G
Frew, AJ
Morad, M
Priori, SG
Ongini, E
Affrime, MB
Citation: Jt. Barbey et al., Cardiovascular safety of second-generation antihistamines, AM J RHINOL, 13(3), 1999, pp. 235-243
Authors:
Barbey, JT
Sale, ME
Woosley, RL
Shi, J
Melikian, AP
Hinderling, PH
Citation: Jt. Barbey et al., Pharmacokinetic, pharmacodynamic, and safety evaluation of an accelerated dose titration regimen of sotalol in healthy middle-aged subjects, CLIN PHARM, 66(1), 1999, pp. 91-99
Risultati:
1-8
|